课题基金 / 基金详情

Establishment of the periodontal ligament regeneration with mesenchymal stem cells

Establishment of the periodontal ligament regeneration with mesenchymal stem cells
间充质干细胞牙周膜再生的建立
批准号:
15592165
负责人:
TANIMOTO Kotaro
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

TANIMOTO Kotaro的其他基金

相似基金

相关文献

中文摘要
翻译
我们研究了生长因子对间充质干细胞(MSC)增殖和分化的影响。我们成功地在I型胶原凝胶上培养了兔骨髓间充质干细胞。bFGF对MSC的分化有抑制作用,对MSC的增殖有促进作用。TGF-β可诱导MSC向软骨细胞分化,Hyglyconan在软骨细胞外基质的合成中起重要作用。我们阐明了软骨细胞分化过程中透明质酸代谢受透明质酸合成酶(HAS 2,3)和透明质酸酶(HAYL 1,2)调节。这些酶与软骨细胞的肥大密切相关(Suzuki A.,等,Biochim Biophys Acta.,1743(1-2),2005)。(Tanimoto K.,318(2),2005)。此外,消化牙周膜周围的透明质酸可抑制牙周膜细胞的增殖,促进胶原合成。我们还研究了细胞外基质分子对牙周膜细胞增殖和分化的影响。RGD-CAP蛋白通过cDNA连接载体过量表达。siRNA用于抑制PDL上RGD-CAP蛋白的合成。最后,阐明了PDL中的钙化活性通过添加RGD-CAP而受到抑制(Doi T.,例如,口腔生物学文献,48(8),2003)。
英文摘要
We examined the effects of growth factors on the proliferation and differentiation of mesenchymal stem cells (MSC). We successfully cultured MSC derived from bone marrow of rabbit on type I collagen gel. The inhibition of differentiation and enhancement of proliferation of MSC was observed by addition of bFGF. Furthermore, it was suggested that MSC differentiate to chondrtocytes by addition of TGF-beta.Hyaluronan has a crucial roles in synthesis of extra cellular matrix of cartilage. We clarified that the hyaluronan metabolism during the chondrocyte differentiation is modulated by hyaluronan synthase (HAS2, 3) and hyaluronidase (HAYL 1, 2). These enzymes closely contributed to the hypestrophy of chondrocytes (Suzuki A., et al. Biochim Biophys Acta., 1743(1-2), 2005). (Tanimoto K., et al. Cell Tissue Res. 318(2), 2005). Furthermore, the digestion of hyaluronan around PDL caused the inhibition of proliferation and enhancement of collagen synthesis in PDL.We also examined the effects of extra cellular matrix molecules on the proliferation and differentiation of periodontal ligament cells (PDL). RGD-CAP protein was over-expressed by cDNA ligated vectors. The siRNA was used for suppression of RGD-CAP protein synthesis on PDL. Finally, it was clarified that activity of calcification in PDL is inhibited by addition of RGD-CAP (Doi T., et al., Arch Oral Biol., 48(8), 2003).
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s00441-004-0966-7
发表时间: 2004-11-01
期刊: CELL AND TISSUE RESEARCH
影响因子: 3.6
作者: [Tanimoto, K, Suzuki, A, Tanne, K]
通讯作者: Tanne, K
DOI: 10.1177/154405910508400111
发表时间: 2005-01
期刊: Journal of Dental Research
影响因子: 7.6
作者: [N. Tanaka;S. Ohno;K. Honda;K. Tanimoto;T. Doi;M. Ohno-Nakahara;E. Tafolla;S. Kapila;K. Tanne]
通讯作者: N. Tanaka;S. Ohno;K. Honda;K. Tanimoto;T. Doi;M. Ohno-Nakahara;E. Tafolla;S. Kapila;K. Tanne
The metabolism of hyaluronan in cultured rabbit growth plate Chondrocytes during differentiation.
培养兔生长板软骨细胞分化过程中透明质酸的代谢。
DOI: --
发表时间: 2005
期刊: Biochim Biophys Acta. 1742(1-2)
影响因子: --
作者: [Suzuki A., Tanimoto K., Ohno S., et al.]
通讯作者: et al.
Mechanical stimuli enhances the expression of RGD-CAP/betaig-h3 in the periodontal ligament.
机械刺激增强牙周膜中 RGD-CAP/betaig-h3 的表达。
DOI: --
发表时间: 2003
期刊: Arch Oral Biol. 48・8
影响因子: --
作者: [Doi T, Ohno S, Tanimoto K, et al.]
通讯作者: et al.
8
    Role of osteocytes in the progression of malignant tumors with bone lesions
    • 批准号:
      21K21016
    • 项目类别:
      Grant-in-Aid for Research Activity Start-up
    • 资助金额:
      $2.0万
    • 财政年份:
      2021
    • 负责人:
      TANIMOTO Kotaro
    • 依托单位:
    国内基金
    海外基金
    乳腺癌转移淋巴结微环境CD24hiCD27+B细胞上调肿瘤细胞PDL1诱导免疫逃逸的机制及靶向干预研究
    • 批准号:
      Z25H160012
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      张婷
    • 依托单位:
    肺癌外周血淋巴细胞亚群预测anti-PD1/PDL1疗效的鉴定及应用研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      仇凤启
    • 依托单位:
    三阴性乳腺癌通过JNK-METTL3-PDL1轴促进肝转移的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      陈阳
    • 依托单位:
    一碳代谢(One carbon metabolism)介导上调的 PD1/PDL1 驱动 肿瘤免疫逃逸
    • 批准号:
      2024JJ9491
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      彭罗根
    • 依托单位: